1 Table of Contents

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 18

2 Introduction 19
2.1 Cardiovascular Surgery Devices Overview 19

3 Products under Development 21
3.1 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 21
3.2 Cardiovascular Surgery Devices - Pipeline Products by Segment 22
3.3 Cardiovascular Surgery Devices - Pipeline Products by Territory 23
3.4 Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 24
3.5 Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 25
3.6 Cardiovascular Surgery Devices - Ongoing Clinical Trials 26

4 Cardiovascular Surgery Devices - Pipeline Products under Development by Companies 27
4.1 Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 27
4.2 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 31

5 Cardiovascular Surgery Devices Companies and Product Overview 35
5.1 3DT Holdings LLC Company Overview 35
5.2 AblaCor Medical Corporation Company Overview 36
5.3 Adagio Medical Inc. Company Overview 38
5.4 Advanced Catheter Therapies Inc Company Overview 41
5.5 AdvanSource Biomaterials Corporation Company Overview 43
5.6 AFreeze GmbH Company Overview 44
5.7 AngioDymics Inc Company Overview 48
5.8 Apaxis Medical Inc Company Overview 50
5.9 APK Advanced Medical Technologies, Inc. Company Overview 53
5.10 Applied Medical Resources Corporation Company Overview 54
5.11 AtriCure Inc Company Overview 55
5.12 Axcelon Biopolymers Corp. Company Overview 59
5.13 Beth Israel Deaconess Medical Center Inc Company Overview 60
5.14 Bioretec Ltd Company Overview 62
5.15 Boston University Company Overview 63
5.16 CardioPolymers Inc Company Overview 64
5.17 CardioPrecision Ltd Company Overview 65
5.18 CardioScout, LLC Company Overview 66
5.19 Cardious Inc Company Overview 67
5.20 Centre Hospitalier Universitaire de Nice Company Overview 68
5.21 Children’s Hospital Boston Company Overview 69
5.22 Cincinti Children’s Hospital Medical Center Company Overview 72
5.23 Circulatory Technology Inc. Company Overview 73
5.24 Cleveland Clinic Hospital Company Overview 74
5.25 Corazon Technologies, Inc. Company Overview 75
5.26 Coromedic Ltd. Company Overview 76
5.27 CPSI Biotech Company Overview 78
5.28 Cytograft Tissue Engineering Inc (Ictive) Company Overview 79
5.29 Daidalos Solutions BV Company Overview 81
5.30 Design Mentor, Inc. Company Overview 85
5.31 Edwards Lifesciences Corp Company Overview 86
5.32 Ela bv Company Overview 88
5.33 Elsius Biomedical Inc Company Overview 90
5.34 Endogene Ltd Company Overview 91
5.35 Enigma Medical, Inc. Company Overview 93
5.36 EpiEP, Inc. Company Overview 94
5.37 Getinge AB Company Overview 95
5.38 Graft-Loc Inc. Company Overview 96
5.39 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 97
5.40 Hadassah Medical Center Company Overview 98
5.41 Hancock Jaffe Laboratories Inc Company Overview 100
5.42 Harpoon Medical, Inc. Company Overview 101
5.43 HeartLander Surgical, Inc. Company Overview 104
5.44 HeartStitch Inc. Company Overview 105
5.45 Helical Solutions, Inc. (Ictive) Company Overview 106
5.46 Hemovent GmbH Company Overview 107
5.47 Humacyte Inc Company Overview 108
5.48 iiTech BV Company Overview 109
5.49 Johns Hopkins University Company Overview 111
5.50 Kardium Inc Company Overview 112
5.51 LaunchPoint Technologies, Inc. Company Overview 115
5.52 LeMaitre Vascular Inc Company Overview 116
5.53 LivaNova PLC Company Overview 120
5.54 LuxCath, LLC Company Overview 123
5.55 Magenta Medical Inc Company Overview 124
5.56 McGill University Company Overview 125
5.57 MedArray Inc. Company Overview 126
5.58 Miracor Medical Systems GmbH Company Overview 129
5.59 Mosh University Company Overview 130
5.60 Neograft Technologies Inc Company Overview 131
5.61 Nido Surgical LLC Company Overview 132
5.62 Nikkiso Co Ltd Company Overview 133
5.63 Nipro Corp Company Overview 134
5.64 Northwestern University Company Overview 136
5.65 Occlutech Intertiol AB Company Overview 137
5.66 Peca Labs, Inc. Company Overview 140
5.67 PetVivo Holdings Inc Company Overview 141
5.68 Prekubator TTO Company Overview 142
5.69 Rafael Medical Technologies, Inc. Company Overview 143
5.70 RegenMedTX LLC Company Overview 144
5.71 Replication Medical Inc Company Overview 145
5.72 Rox Medical Inc Company Overview 146
5.73 RWTH Aachen University Company Overview 147
5.74 SeamVad Ltd. Company Overview 148
5.75 SentreHEART, Inc. Company Overview 149
5.76 Sheba Medical Center Company Overview 152
5.77 Sichuan Jinjiang Electronic Science and Technology Co., Ltd. Company Overview 153
5.78 Southern Research Institute Company Overview 154
5.79 Spectranetics Corp Company Overview 155
5.80 Sree Chitra Tirul Institute for Medical Sciences & Technology Company Overview 156
5.81 Stanford University Company Overview 158
5.82 Sunnybrook Health Sciences Centre Company Overview 160
5.83 Terumo Cardiovascular Systems Corporation Company Overview 161
5.84 Thermedical Inc Company Overview 163
5.85 Thoratec Corp Company Overview 168
5.86 Tissue Regeneration Technologies LLC Company Overview 170
5.87 TransMed7 LLC Company Overview 171
5.88 Tufts Medical Center Company Overview 172
5.89 University College London Company Overview 173
5.90 University of Arizo Company Overview 174
5.91 University of California Los Angeles Company Overview 175
5.92 University of Chicago Company Overview 177
5.93 University of Florida Company Overview 178
5.94 University of Iowa Company Overview 179
5.95 University of Michigan Company Overview 181
5.96 University of Montreal Company Overview 182
5.97 University of Nebraska Company Overview 183
5.98 University of Pittsburgh Company Overview 184
5.99 University of Strathclyde Company Overview 185
5.100 University of Utah Company Overview 186
5.101 Vigor Medical Technologies Ltd. Company Overview 187
5.102 Vivonics, Inc. Company Overview 188
5.103 VytronUS, Inc. Company Overview 189
5.104 W-Z BIOTECH, LLC Company Overview 192

6 Cardiovascular Surgery Devices- Recent Developments 194
6.1 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 194
6.2 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi 194
6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Fincial Results 194
6.4 May 23, 2018: Admedus Announce Appointment of Catherine Costello 197
6.5 May 17, 2018: Mr. Jothan Chen Promoted to Chief Intertiol Business Officer of MPSC 197
6.6 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 197
6.7 May 15, 2018: Getinge announces its commitment to EuroPCR 198
6.8 May 14, 2018: Positive findings in the PrimECC study 198
6.9 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 199
6.10 May 14, 2018: Maging Director at Elos Medtech Timmersdala is appointed 200
6.11 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary’s Associate as the Fifth Terumo Fellow 200
6.12 May 09, 2018: U.S. Stem Cell Reports First Quarter Results 200
6.13 May 09, 2018: Sanofi lays off 95 workers in Framingham 201
6.14 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Fincial Officer and Key Magerial Personnel 201
6.15 May 08, 2018: Mallinckrodt Reports First Quarter 2018 Results 201
6.16 May 08, 2018: Elos Medtech expands Onyx Medical in the United States 203
6.17 May 07, 2018: Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Magement Systems Due to Revised Cleaning Instructions 203
6.18 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 204
6.19 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility 205
6.20 May 07, 2018: Scott & White Medical Center - Temple Performs 500th TAVR Procedure 205
6.21 May 03, 2018: 10 Years of Digital Chest Draige: Medela’s Milestones Show How State-Of-The-Art Technology Has Transformed Today’s Post-Operative Patient Care 206
6.22 May 03, 2018: Cardil Health Announces Third-quarter Results for Fiscal Year 2018 206
6.23 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 208
6.24 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 208
6.25 May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Fincial Results 209
6.26 May 02, 2018: CryoLife Announces First Quarter 2018 Fincial Results 211
6.27 May 01, 2018: Admedus mes Michael Oswell As Vice President, Development 212

7 Appendix 445
7.1 Methodology 445
7.2 About GlobalData 448
7.3 Contact Us 448
7.4 Disclaimer 448